Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-003420

Chief Executive Officer gave up 481,088 shares (to pay taxes)

  • Chief Executive Officer acquired 800,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2021-01-22 Option exercise +800,000 $4.42 $3,536,000 3,299,214 D
BELANOFF JOSEPH K Chief Executive Officer 2021-01-22 Shares withheld for taxes −481,088 $28.06 $13,499,329 2,818,126 D
Derivatives
BELANOFF JOSEPH K Chief Executive Officer 2021-01-22 Option exercise · Stock Option (Right to Buy) −800,000 0 D
Loading xslF345X03/doc4.xml…